ATE427961T1 - Mit fettzellendifferenzierung assoziiertes gen und protein - Google Patents

Mit fettzellendifferenzierung assoziiertes gen und protein

Info

Publication number
ATE427961T1
ATE427961T1 AT02796967T AT02796967T ATE427961T1 AT E427961 T1 ATE427961 T1 AT E427961T1 AT 02796967 T AT02796967 T AT 02796967T AT 02796967 T AT02796967 T AT 02796967T AT E427961 T1 ATE427961 T1 AT E427961T1
Authority
AT
Austria
Prior art keywords
gene
cell differentiation
protein associated
fat cell
seq
Prior art date
Application number
AT02796967T
Other languages
English (en)
Inventor
Masayoshi Imagawa
Yuichi Oku
Original Assignee
Nissui Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissui Pharm Co Ltd filed Critical Nissui Pharm Co Ltd
Application granted granted Critical
Publication of ATE427961T1 publication Critical patent/ATE427961T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02796967T 2001-12-07 2002-12-05 Mit fettzellendifferenzierung assoziiertes gen und protein ATE427961T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001374785 2001-12-07

Publications (1)

Publication Number Publication Date
ATE427961T1 true ATE427961T1 (de) 2009-04-15

Family

ID=19183291

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02796967T ATE427961T1 (de) 2001-12-07 2002-12-05 Mit fettzellendifferenzierung assoziiertes gen und protein

Country Status (7)

Country Link
US (1) US7351551B2 (de)
EP (1) EP1462518B1 (de)
JP (1) JP4504682B2 (de)
AT (1) ATE427961T1 (de)
CA (1) CA2469524A1 (de)
DE (1) DE60231913D1 (de)
WO (1) WO2003048358A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10766927B2 (en) 2012-11-25 2020-09-08 The Regents Of The University Of California Peptides that stimulate subcutaneous adipogenesis
US10844102B2 (en) 2014-05-28 2020-11-24 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH063358A (ja) 1992-06-23 1994-01-11 Nitsusui Seiyaku Kk 免疫分析用試薬
DE69432897T2 (de) 1993-05-10 2004-05-27 Nissui Pharmaceutical Co., Ltd. Verfahren zur bestimmung von mehr als einem immunologischen liganden und bestimmungsreagenz sowie satz dafuer
JPH08333394A (ja) 1995-04-03 1996-12-17 Takeda Chem Ind Ltd ラット肥満遺伝子、その遺伝子産物およびその製造法
JPH09292397A (ja) 1996-04-26 1997-11-11 Nissui Pharm Co Ltd バイオセンサ、キット、生体物質の分析方法及びバイオセンサの製造方法
JPH10253632A (ja) 1997-03-10 1998-09-25 Nissui Pharm Co Ltd 分析方法、キット及び装置
JPH1175865A (ja) 1997-05-21 1999-03-23 Smithkline Beecham Corp 分泌ネズミ・蛋白ｓｄｆ５に類似したヒト・遺伝子（ａｔｇ−１６２２）
CN1315448A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人微球蛋白转录调控因子30和编码这种多肽的多核苷酸
AU2002329784A1 (en) * 2001-08-17 2003-03-03 Incyte Genomics, Inc. Molecules for disease detection and treatment

Also Published As

Publication number Publication date
DE60231913D1 (de) 2009-05-20
JPWO2003048358A1 (ja) 2005-04-14
EP1462518A1 (de) 2004-09-29
CA2469524A1 (en) 2003-06-12
US7351551B2 (en) 2008-04-01
JP4504682B2 (ja) 2010-07-14
US20050164183A1 (en) 2005-07-28
EP1462518A4 (de) 2005-10-12
EP1462518B1 (de) 2009-04-08
WO2003048358A1 (fr) 2003-06-12

Similar Documents

Publication Publication Date Title
PL2071028T3 (pl) Pochodzący z WT1 peptyd antygenowy wiążący się z HLA-DR
ATE430197T1 (de) Fibroblasten wachstumsfaktor-ähnliche polypeptide
CY1108511T1 (el) Θεραπευτικες παραλλαγες της λιποπρωτεϊνικης λιπασης (lpl)
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
WO2002061076A1 (en) Adiponectin-associated protein
EP1501936A4 (de) Cytokin-proteinfamilie
ATE427961T1 (de) Mit fettzellendifferenzierung assoziiertes gen und protein
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
ATE463507T1 (de) Neue mittel zur prävention von leishmaniose
DE60124380D1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
EP1634951A4 (de) Neues protein
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
DE60143299D1 (de) Unter salzstress erhöhte expression aufweisende nukleinsäuren und proteine
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2003018806A1 (fr) Nouveau gene humain bmcc1
EP0787798A3 (de) GRP17 Gen
WO2003087352A3 (en) Enolase polypeptides and structures
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
WO2003089461A3 (en) Purified dutpase from helicobacter pylori
CA2439182A1 (en) Novel calcium-independent phospholipases a2, genes thereof and promoter of the same
WO2004081165A3 (en) Novel purified dihydrodipicolinate synthase polypeptides and structures thereof
BR0107799A (pt) Proteìna de interação de wt1 wtip

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties